Related Experiment Video
Updated: May 9, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Low serum testosterone as a new risk factor for chronic rejection in heart transplanted men
Nicola Caretta1, Giuseppe Feltrin, Giuseppe Tarantini
1Department of Molecular Medicine, Centre for Human Reproduction Pathology, University of Padova, Padova, Italy. ncaretta@gmail.com
Insights
Low testosterone levels in men are linked to cardiac allograft vasculopathy (CAV) after heart transplantation. This study found lower testosterone levels in patients with CAV, suggesting a direct and indirect role in its development.
Area of Science:
- Cardiology
- Endocrinology
- Transplantation Immunology
Background:
- Cardiac allograft vasculopathy (CAV) is a major complication after heart transplantation (HTx), representing chronic rejection.
- Low testosterone levels in men have been associated with cardiovascular disease.
- The relationship between testosterone levels and CAV development requires further investigation.
Purpose of the Study:
- To evaluate the influence of plasma testosterone levels on the development of CAV in male heart transplant recipients.
- To explore the association between testosterone levels and cardiovascular risk factors in HTx patients.
Main Methods:
- Prospective observational study of male HTx patients.
- Comprehensive assessments including medical history, physical examination, biochemical tests, hormone levels, echocardiography, coronary flow velocity reserve, and coronary angiography.
- Measurement of total and free testosterone plasma levels.
Main Results:
- Patients with CAV exhibited significantly lower total and free testosterone levels compared to No-CAV patients.
- Lower testosterone levels were negatively correlated with cardiovascular risk factors like cholesterol and fasting blood glucose.
- Free testosterone levels were identified as independent predictors of CAV development.
Conclusions:
- Testosterone plasma levels significantly influence CAV development in heart transplant recipients.
- This influence is mediated both indirectly, by affecting traditional risk factors, and directly, potentially through modulation of the alloimmune response.
- Free testosterone is a key predictor for CAV in this population.
Background:
Among the various complications of heart transplantation (HTx), the vasculopathy of the allograft (CAV), a phenomenon of chronic rejection, is still a serious problem. Recently, the literature has shown that low testosterone levels in men are associated with cardiovascular disease. In this study, we evaluated the influence of testosterone plasma levels on CAV development.
Methods:
We studied, with a prospective observational study, all consecutive male HTx patients evaluated from May 2010 to June 2011 at our center. All subjects underwent accurate medical history collection, physical examination, biochemical blood tests, hormone levels, transthoracic Doppler echocardiography, coronary flow velocity reserve assessment, and coronary angiogram.
Results:
HTx subjects with CAV had significant lower total testosterone plasma levels (12.9±3.9 vs. 15.8±5.8 nmol/L), free testosterone (0.26±0.07 vs. 0.31±0.08 nmol/L), and coronary flow velocity reserve (2.35±0.60 vs. 2.81±0.78 s) with respect to No-CAV patients. Considering the patients as a whole group, a significant negative relation was found between free and total testosterone plasma levels and some cardiovascular risk factors (cholesterol and fasting blood glucose). A significant linear inverse relation was found between total and free testosterone plasma levels and CAV grading. Only free testosterone plasma levels were independent predictors for CAV.
Conclusions:
We showed for the first time the influence of testosterone plasma levels on CAV development: indirectly increasing traditional risk factors and directly with a probable influence on alloimmune response.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
